Integrating Artificial Intelligence with Virtual Screening: A New Era in Drug Discovery addresses the evolving landscape of drug discovery by combining traditional virtual screening with cutting-edge artificial intelligence technologies. This volume offers an interdisciplinary guide to AI-driven ligand and structure-based screening methods, including machine learning, deep learning, and generative models, thus enabling faster and more accurate identification of drug candidates. It covers mathematical models, computational workflows, and optimization strategies such as Pareto-based and physics-based approaches.
Sections also discuss challenges in navigating ultra-large chemical libraries and present practical case studies that demonstrate real-world applications. Edited by leading researchers, the book provides authoritative insights suited for graduate students, researchers, and industry professionals. Users will be empowered by the latest tools and knowledge to innovate drug discovery pipelines and support the development of precision medicines and foster advancements in pharmaceutical sciences.
Inhaltsverzeichnis
1. Introduction: Integrating AI and Virtual Screening in Modern Drug Discovery
2. AI-Driven Approaches in Virtual Screening: An Overview
3. AI in Ligand-Based Virtual Screening
4. AI in Structure-Based Virtual Screening
5. Generative AI for Molecular Design and Virtual Screening
6. Optimizing Virtual Screening Scores through Artificial Intelligence
7. Integrating Active Learning with Virtual Screening for Smarter Drug Discovery
8. Navigating Ultra-Large Chemical Libraries: Challenges and AI-Enabled Solutions
9. Pareto-Based Optimization Strategies in Machine Learning and AI-Driven Models
10.Free Energy and Physics-Based Optimization: Enhancing Accuracy in Virtual Screening / Refining Virtual Screening through Physics-Based and Hybrid AI Methods
11. Multi-Method Virtual Screening: Enhancing Predictive Accuracy and Reliability in Drug Discovery
12. Integration of Fragment-Based Drug Design (FBDD) with Virtual Screening
13. Pharmacophore Modeling Enhanced by Neural and Subgraph Matching Techniques
14. Next-Generation Target Modeling and AI-Enhanced Structure-Based Screening: Bridging Innovation with Industrial Applications
15. AI-Driven Activity / ADMET / Property Prediction